Therefore, we postulate that the bimodal therapy induced neo-angiogenesis-triggered glycogen consumption in surviving (e.g., autophagic) tumor cells through an HIF-1α-independent mechanism (absence of hypoxia), which was particularly driven by magnetic hyperthermia (see below). This evidence concerns the gene HIF1A and neoplasm.